Ph Health Drug Patent Portfolio
Ph Health owns 3 orange book drugs protected by 25 US patents Given below is the list of Ph Health's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10869845 | Ephedrine compositions and methods | 22 Jan, 2040 | Active |
| US12029710 | Ephedrine compositions and methods | 22 Jan, 2040 | Active |
| US10653646 | Epinephrine compositions and containers | 21 Mar, 2039 | Active |
| US11083698 | Epinephrine compositions and containers | 21 Mar, 2039 | Active |
| US11207280 | Epinephrine compositions and containers | 21 Mar, 2039 | Active |
| US12133837 | Epinephrine compositions and containers | 21 Mar, 2039 | Active |
| US10130592 | Epinephrine formulations | 13 Mar, 2035 | Active |
| US12280024 | Epinephrine formulations | 13 Mar, 2035 | Active |
| US9119876 | Epinephrine formulations | 13 Mar, 2035 | Active |
| US9295657 | Epinephrine formulations | 13 Mar, 2035 | Active |
| US10010575 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US12186362 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9375478 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9687526 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9744209 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9744239 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9750785 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9919026 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9925233 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9925234 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9937223 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9962422 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9968649 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9974827 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
| US9981006 | Vasopressin formulations for use in treatment of hypotension | 30 Jan, 2035 | Active |
Latest Legal Activities on Ph Health's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ph Health.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 05 Jun, 2024 | US10869845 (Litigated) |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 30 May, 2024 | US10869845 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Nov, 2023 | US9375478 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 12 Oct, 2023 | US10653646 |
|
Email Notification
Critical
| 30 Mar, 2023 | US10869845 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Mar, 2023 | US10869845 (Litigated) |
|
Correspondence Address Change
Critical
| 28 Mar, 2023 | US10869845 (Litigated) |
|
Email Notification
Critical
| 06 Mar, 2023 | US11207280 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 06 Mar, 2023 | US11207280 |
|
Correspondence Address Change
Critical
| 01 Mar, 2023 | US11207280 |
|
Email Notification
Critical
| 27 Feb, 2023 | US10653646 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 27 Feb, 2023 | US10653646 |
|
Email Notification
Critical
| 24 Feb, 2023 | US11083698 |
|
Email Notification
Critical
| 24 Feb, 2023 | US10869845 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 24 Feb, 2023 | US11083698 |
Ph Health's Family Patents
Ph Health drugs have patent protection in a total of 7 countries. It has a significant patent presence in the US with 88.9% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Ph Health Drug List
Given below is the complete list of Ph Health's drugs and the patents protecting them.
1. Adrenalin
Adrenalin is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10653646 | Epinephrine compositions and containers |
21 Mar, 2039
(13 years from now)
| Active |
| US11083698 | Epinephrine compositions and containers |
21 Mar, 2039
(13 years from now)
| Active |
| US11207280 | Epinephrine compositions and containers |
21 Mar, 2039
(13 years from now)
| Active |
| US12133837 | Epinephrine compositions and containers |
21 Mar, 2039
(13 years from now)
| Active |
| US10130592 | Epinephrine formulations |
13 Mar, 2035
(9 years from now)
| Active |
| US12280024 | Epinephrine formulations |
13 Mar, 2035
(9 years from now)
| Active |
| US9119876 | Epinephrine formulations |
13 Mar, 2035
(9 years from now)
| Active |
| US9295657 | Epinephrine formulations |
13 Mar, 2035
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adrenalin's drug page
2. Ephedrine Sulfate
Ephedrine Sulfate is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10869845 | Ephedrine compositions and methods |
22 Jan, 2040
(14 years from now)
| Active |
| US12029710 | Ephedrine compositions and methods |
22 Jan, 2040
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ephedrine Sulfate's drug page
3. Vasostrict
Vasostrict is protected by 15 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10010575 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US12186362 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9375478 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9687526 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9744209 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9744239 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9750785 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9919026 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9925233 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9925234 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9937223 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9962422 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9968649 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9974827 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
| US9981006 | Vasopressin formulations for use in treatment of hypotension |
30 Jan, 2035
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vasostrict's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List